Cancer treatment—systemic therapy agent name (primary cancer), antineoplastic drug code (Self-Instructional Manual for Tumour Registrars Book 8 3rd edn) X[X(39)]
Identifying and definitional attributes
|Metadata item type:||Data Element|
|Short name:||Systemic therapy agent name|
|Registration status:||Health, Superseded 07/12/2011|
|Definition:||The chemotherapeutic agent or anti-cancer drug used for treatment of the primary cancer, as represented by a code.|
|Data Element Concept:||Cancer treatment—systemic therapy agent name (primary cancer)|
Value domain attributes
|Classification scheme:||Self-Instructional Manual for Tumour Registrars Book 8 Antineoplastic Drugs, 3rd edition|
|Maximum character length:||40|
Data element attributes
Collection and usage attributes
|Guide for use:|
The purpose of collecting specific treatment information is to account for all treatment types, which may assist in evaluation of effectiveness of different treatment patterns. The actual agents used will sometimes be of interest.
Systemic therapy often involves treatment with a combination of agents. These may be known by acronyms but since details of drugs and acronyms may vary it is recommended that each agent be recorded separately.
Oral chemotherapy normally given on an outpatient basis should also be included.
New codes and names will need to be added as new agents become available for clinical use.
Hormone therapy agents and immunotherapy agents should be recorded under this data element.
The full name of the agent(s) should be recorded if the coding manual is not available.
Collecting dates for systemic therapy will allow evaluation of treatments delivered and of time intervals from diagnosis to treatment, from treatment to recurrence and from treatment to death.
Source and reference attributes
National Cancer Institute Surveillance, Epidemiology and End Results (SEER) Program
Surveillance, Epidemiology and End Results (SEER) Program Self-instructional manual for tumour registrars: Book 8 - Antineoplastic drugs 3rd Edition National Cancer Institute.
|Related metadata references:|
Has been superseded by Cancer treatment—systemic therapy agent or protocol, text X[X(149)] Health, Superseded 08/05/2014
Supersedes Systemic therapy agent name, version 1, DE, NHDD, NHIMG, Superseded 01/03/2005.pdf (15.5 KB)
|Implementation in Data Set Specifications:|
All attributes +
Cancer (clinical) DSS Health, Superseded 07/12/2005
Cancer (clinical) DSS Health, Superseded 06/03/2009
Cancer (clinical) DSS Health, Superseded 22/12/2009
Cancer (clinical) DSS Health, Superseded 07/12/2011